Over the years our studies have been aimed at the preparation of DNA-binding agents containing L-daunosamine, L-acosamine, or their derivatives, and we have found 1-Osilylated 2-deoxy-hexopyranoses to be very valuable as synthetic intermediates and glycosyl donors. We present here efficient strategies for the synthesis and separation of 1-O-silylated 3-azido- and 3-amino-2,3,6-trideoxy-L-hexopyranoses and the design of suitable glycosyl donors towards synthesis of doxorubicin analogs modified at C-4 and C-14. By using a set of known reactions, we generated a mixture of 3-azido-hexopyranoses with L-arabino and L-ribo configurations, hitherto practically unexplored as glycosylating reagents. Two new approaches are described for producing efficient and scaleable resolution of 1-O-silylated azides (epimeric at C-3). The selection of 4-O-protecting groups able to withstand glycosylation conditions, yet suitably labile to allow deprotection under acidic or mild basic conditions, led to strategically important glycosyl donors that allow preparation of previously inaccessible doxorubicin-based DNAbinding glycosides. The described use of 3-azido-2,3,6-trideoxyhexoses constitutes a new strategy for pre- and postglycosylation functionalization of anthracycline antibiotic precursors.
Most of the new drug candidates in the anthracycline class of antitumor antibiotics are a result of synthetic efforts involving modification of both the aglycone and sugar moieties. In such an approach, formation of a glycosidic bond is an important step that often becomes a limiting factor in the preparation of certain target structures and can also affect the efficiency of synthetic processes for obtaining analogs of anthracycline antibiotics of clinical interest. We have developed a general approach to de novo glycosylation of anthracycline aglycones leading to doxorubicin analogs with L-lyxo- and L-arabinomonosaccharides. Such glycosylation procedures are also effective in preparation of daunorubicin congeners. Specifically, we have explored the use of 1-O-silylated 3-azido-2,3,6-trideoxy-hexopyranoses as stable glycosyl donors and have successfully demonstrated the practical use of the 3-azido group to generate an amino function during the last steps of synthesis to allow easy generation of doxorubicin analogs.We have also shown that other known glycosyl donors can be conveniently generated from 1-O-silylated-hexopyranoses and can be used effectively to take advantage of a particular glycosidation and deprotection strategy.We describe two standard glycosylation procedures that were designed to attain the desired level of alfa-glycoside stereoselectivity and overall efficiency. Different glycosylation procedures were selected depending on the sugar synthon configuration and sensitive C-14 substitution in the target anthracycline aglycone. These achievements are exemplified by the use of previously unreported 3-azidosugar synthons of L-lyxo- and L-arabino- configuration protected by a 4-O-chloroacetyl group or an acid-labile triethylsilyl (TES) protecting group.
The circular dichroism (CD) spectra of a variety of vic-amino alcohols in the presence of chlorotetrabutyratodiruthenium(II,III) as an auxiliary chromophore were measured in acetonitrile and chloroform. The method was tested in several model compounds containing acyclic and cyclic amino alcohols, and among them biologically important adrenergic drugs and amino sugars. The study demonstrated that the sign of the Cotton effects obtained is determined by the preferred helicity of the O-C-C-N unit in the chiral complex formed in situ. On this basis, a rule was formulated that correlates a positive (negative) sign of the O-C-C-N torsional angle with a positive (negative) Cotton effect arising around 350 nm and/or with negative (positive) signs of CD spectra bands occurring around 300 and 400 nm.
4
Dostęp do pełnego tekstu na zewnętrznej witrynie WWW
While natural anthracycline antibiotics retain their position of clinically important antitumor drugs despite of serious side effects, much effort is directed towards their improvement by rational structural changes. Most of useful anthracycline antibiotics chemistry is done by dissconnection - modification approach, folloved by de novo glycosidic bond assembly. It is pointed out that 1,2- and 2,3-unasturated pyranosides constitute an important class of intermediates, useful for synthesis of natural and modified antibiotic aminosugars. Glycals derived from 3-amino-2,3,6-trideoxypyranoses and their 1-O-silylated derivatives are useful glycosyl donors for a variety of alcohols. Also anthracycline antibiotics can be obtained from them in simple preparative procedures which are amenable for scale up and technical process development. Moreover, unsaturated pyranoses from 6-deoxy-L- configurational series are useful chiral precursors for anthracycline aglycons synthesis. Remarkably, various synthetic schemes comprising anthracycline antibiotic sugars, aglycons and new synthetic analogues can be traced down to the single common precursor: 3,4-di-O-acetyl-L-rhamnal, easily obtained from a commodity chemical (raw material in food industry) L-rhamnose.
Synthesis of the sugar portion (kedarosamine) of a recently discovered chromoprotein antitumor antibiotic and spiroketal-macrolide A82548A is described. Kedarosamine was prepared from readily available methyl A-L-rhamnoside. This route can also be used to prepare different glycosyl donors and analogues of kedarosamine potentially useful in the synthesis of biologically important congeners.
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.